Is Integ. Proteins overvalued or undervalued?

As of 19 September 2025, the valuation grade for Integ. Proteins has moved from risky to fair, indicating a more stable outlook for the company. Based on the analysis, Integ. Proteins is currently fairly valued. The company's PE ratio stands at 13.34, while its EV to EBITDA ratio is also 13.31, suggesting that it is aligned with its earnings potential. Additionally, the PEG ratio is notably low at 0.10, indicating potential growth at a reasonable price.
In comparison to its peers, Integ. Proteins shows a more favorable valuation than Manorama Industries, which has a PE ratio of 57.18 and is classified as very expensive. On the other hand, CIAN Agro, which is also rated fair, has a significantly higher PE ratio of 45.93. Notably, Integ. Proteins has outperformed the Sensex over the long term, with a remarkable 10-year return of 1444.68%, although it has faced challenges recently with a year-to-date decline of 51.72%.